Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06335628

Volumetric Dimensional Changes After Surgical Pontic Site Development Procedures With Connective Tissue Graft or Collagen Matrix

The aim of this research project is to compare two surgical procedures to improve soft tissue volume. Both procedures have already been validated, but despite their great clinical relevance, little data exists in the literature. With this study, the investigators aim to evaluate volumetric changes of connective tissue graft versus biomaterial (membrane). In addition, further clinical measurements will be taken and patient satisfaction will be assessed.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Bern

Bern, 3010, Switzerland

Location status: Recruiting

Location contact

Manrique Fonseca, Dr. med. dent.

PRINCIPAL_INVESTIGATOR

Martin Schimmel, Prof.

CONTACT

[email protected]

+41316840630

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed Consent signed by the subject
  • Age ≥ 18 years
  • Willingness to sign informed consent and to participate in the study
  • Single tooth gap or extended edentulous space in the lower or posterior jaw including a pontic site with a soft tissue deficiency.
  • Tooth gap of ≥ 8 mm.
  • Presence of natural or artificial opposing dentition
  • Sufficient vertical interocclusal space of an implant restoration (7mm)
  • Bounded by natural and periodontally stable teeth
  • Treatment plan must include tooth replacement with an implant or tooth-supported fixed dental prosthesis.

Exclusion criteria

  • Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance with the protocol
  • Severe bruxism, clenching habits, or presence of oro-facial pain
  • Uncontrolled diabetes mellitus (HbA1c >7.0)
  • Clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.)
  • Any active oral or systemic acute infections
  • Currently receiving chemo- or radiotherapy or a history of radiotherapy in the head and neck area
  • Severe hematologic disorders
  • Any other diseases or medications that may compromise normal wound healing
  • Pregnancy or nursing mother
  • Contraindications and limitations of the MD as described in the instructions for use: during pregnancy or lactation, children, presence of acute infection in the surgical area, patients with known sensitivity to porcine material or collagen allergies.
  • Vulnerable subjects
  • Known or suspected non-compliance
  • Drug or alcohol abuse
  • Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc.
  • Participation in another investigation with an investigational drug or another MD within the 30 days preceding and during the present investigation,
  • Enrolment of the PI, his/her family members, employees and other dependent persons

Treatment and study plan

Geistlich Fibro-Gide®

Device

Geistlich Fibro-Gide® is intended to be used as an implantable device for regeneration and augmentation of soft tissue in oral and maxillofacial surgery.

Primary outcomes

  1. Volumetric dimensional changes

    Time frame: 0-5 years

    To assess the volumetric dimensional changes in pontic sites after site development using CTG compared to VCMX

Secondary outcomes

  1. Clinical: PPD

    Time frame: 0-5 years

    Clinical: Probing depth in neighboring teeth

  2. Clinical BoP

    Time frame: 0-5 years

    Clinical: Bleeding on probing

  3. Clinical: Suppuration

    Time frame: 0-5 years

    Clinical: Suppuration on probing

  4. Clinical: Mucosa

    Time frame: 0-5 years

    Clinical: Apical migration of the marginal mucosa

  5. Clinical: ktw

    Time frame: 0-5 years

    Clinical: Keratinized tissue width

  6. Clinical: Mobility

    Time frame: 0-5 years

    Clinical: Mobility

  7. Clinical: Thickness

    Time frame: 0-5 years

    Clinical: Mucosal thickness

  8. Clinical: Contributing factors

    Time frame: 0-5 years

    Clinical: Presence of local contributing factors

  9. Patient-reported satisfaction

    Time frame: 0-5 years

    Questionnaire: Overall patient satisfaction with the treatment provided

  10. Patient-reported esthetics

    Time frame: 0-5 years

    Questionnaire: Esthetics

  11. Patient-reported discomfort

    Time frame: 0-5 years

    Questionnaire: Discomfort

  12. Patient-reported pain

    Time frame: 0-5 years

    Questionnaire: Pain

  13. Prosthetics Survival

    Time frame: 0-5 years

    Prosthetic-related: Fixed dental prostheses survival rates

  14. Prosthetics Success

    Time frame: 0-5 years

    Prosthetic-related: Fixed dental prostheses success rates

  15. Prosthetics Complications

    Time frame: 0-5 years

    Prosthetic-related: Technical complications

  16. Prosthetics PES-WES

    Time frame: 0-5 years

    Prosthetic-related: Esthetic score (PES-WES)

  17. Prosthetics: Occlusal

    Time frame: 0-5 years

    Prosthetic-related: Occlusal contacts (static and dynamic)

  18. Prosthetics: Interproximal

    Time frame: 0-5 years

    Prosthetic-related: Presence of interproximal contacts.

  19. Radiographics BL

    Time frame: 0-5 years

    Marginal bone levels

  20. Radiographics PP

    Time frame: 0-5 years

    Periapical pathosis

  21. Radiographics distance

    Time frame: 0-5 years

    Distance from the adjacent teeth/implants

  22. Radiographics Contacts

    Time frame: 0-5 years

    Presence of open contacts

Study contacts

Contact information is provided by the study sponsor or research team.

Manrique Fonseca, DDS

CONTACT

[email protected]

+41316840630

Sponsors and collaborators

Lead sponsor

University of Bern

Other

Registry information

Important dates

Study start
2024
Primary completion
2027
Study completion
2030
First posted
Mar 28, 2024
Registry last updated
May 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.